Share this post on:

Product Name :
AT-7867

Search keywords :
AT7867

drugId :
null

Target Vo:
Serine/threonine-protein kinase AKT1

Target Vo Short Name :
AKT1

Moa_Name:

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Astex Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ras Rabbit mAb manufacturer
PDCD4 Rabbit mAb manufacturer
Beta Actin Antibody HRP Conjugated: Beta Actin Antibody HRP Conjugated is a rabbit-derived HRP-conjugated antibody targeting beta-Actin with a molecular weight of approximately 42 KDa. Beta Actin Antibody HRP Conjugated can be used for WB experiments in human, mouse, rat, zebrafish, monkey, hamster, plant backgrounds.

Share this post on:

Author: Interleukin Related